GlaxoSmithKline PLC Director/PDMR Shareholding (6847K)
03 September 2021 - 10:32AM
UK Regulatory
TIDMGSK
RNS Number : 6847K
GlaxoSmithKline PLC
03 September 2021
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mrs V A Whyte
==== ======================================== ==================================================
b) Position/status SVP & Company Secretary
==== ======================================== ==================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ======================================== ==================================================
b) Nature of the Award of Ordinary Shares under the Company's
transaction 2015 Share Value Plan
==== ======================================== ==================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =======================
GBP14.62 10,050
==================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==============================
e) Date of the transaction 2021-08-31
==== ======================================== ==================================================
f) Place of the N/A
transaction
==== ======================================== ==================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Mr D Jackson
==== ======================================== =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
and CEO Office)
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== =====================================================
b) Nature of the Award of Ordinary Shares under the Company's
transaction 2015 Share Value Plan
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
GBP14.62 6,330
===================================================================== =========================
d) Aggregated information N/A
====
Aggregated volume
Price
================================================================== ================================
e) Date of the transaction 2021-08-31
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHVXLBBFKLLBBZ
(END) Dow Jones Newswires
September 03, 2021 04:32 ET (08:32 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
Von Apr 2023 bis Apr 2024